IRMD

MKT CAP:$1B

IRadimed Corporation

Market Cap

$1B

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Healthcare·Medical - Devices·🇺🇸·NASDAQ

Stock Price

$88.80-$6.70 (-7.02%)

Apr 23, 2026

Company Details

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatib...

CEO

Roger E. Susi

IPO Date

Jul 16, 2014

Website

www.iradimed.com

Key Metrics TTM

Revenue

$84M

+14.4% YoY

Net Income

$22M

EPS (Diluted)

$1.75

Free Cash Flow

$17M

Revenue / Share

$6.51

Gross Margin

76.7%

Operating Margin

31.2%

Net Margin

26.8%

FCF Margin

20.1%

P/S

13.6x

P/E

50.6x

Earnings Reports

Q1 2026

May 4, 2026

PENDING

FY 2025

Mar 6, 2026

$84M+14.4%EPS $1.75

Q4 2025

Mar 6, 2026

$23M+17.0%EPS $0.50

Q3 2025

Nov 3, 2025

$21M+15.7%EPS $0.43

Q2 2025

Aug 1, 2025

$20M+13.8%EPS $0.45

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 22	$12M	$9M	$3M
Q2 22	$13M	$10M	$4M
Q3 22	$13M	$11M	$4M
Q4 22	$15M	$11M	$4M
Q1 23	$15M	$12M	$4M
Q2 23	$16M	$12M	$5M
Q3 23	$17M	$13M	$6M
Q4 23	$17M	$13M	$5M
Q1 24	$18M	$13M	$5M
Q2 24	$18M	$14M	$6M
Q3 24	$18M	$14M	$6M
Q4 24	$19M	$15M	$6M
Q1 25	$20M	$15M	$5M
Q2 25	$20M	$16M	$7M
Q3 25	$21M	$16M	$7M
Q4 25	$23M	$17M	$7M

Valuation

Quarter	P/S	P/E
Q1 22	25.4x	109.2x
Q2 22	23.8x	93.3x
Q3 22	22.6x	87.3x
Q4 22	21.4x	88.8x
Q1 23	20.2x	82.8x
Q2 23	19.0x	77.5x
Q3 23	18.1x	69.7x
Q4 23	17.4x	66.2x
Q1 24	16.8x	63.5x
Q2 24	16.4x	61.1x
Q3 24	16.0x	61.1x
Q4 24	15.5x	59.2x
Q1 25	15.1x	57.5x
Q2 25	14.7x	55.1x
Q3 25	14.1x	53.7x
Q4 25	13.6x	50.6x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	$1M	$1M
Q2 22	$2M	$1M
Q3 22	$4M	$3M
Q4 22	$3M	$3M
Q1 23	$5M	-$2M
Q2 23	$4M	$3M
Q3 23	$1M	$953.7K
Q4 23	$4M	$3M
Q1 24	$4M	$3M
Q2 24	$7M	$5M
Q3 24	$9M	$5M
Q4 24	$6M	$3M
Q1 25	$4M	$594.6K
Q2 25	$8M	$5M
Q3 25	$7M	$6M
Q4 25	$6M	$5M

Capital Expenditures

Quarter	CapEx
Q1 22	$424.7K
Q2 22	$422.4K
Q3 22	$556.2K
Q4 22	$471.7K
Q1 23	$7M
Q2 23	$378.3K
Q3 23	$439.0K
Q4 23	$632.8K
Q1 24	$478.8K
Q2 24	$1M
Q3 24	$4M
Q4 24	$3M
Q1 25	$4M
Q2 25	$3M
Q3 25	$1M
Q4 25	$482.2K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	+33.5%	+24.0%
Q2 22	+29.7%	+7.4%
Q3 22	+22.9%	+18.6%
Q4 22	+25.2%	+21.1%
Q1 23	+25.7%	+24.2%
Q2 23	+26.8%	+30.5%
Q3 23	+23.1%	+14.3%
Q4 23	+17.4%	+15.9%
Q1 24	+13.7%	+12.1%
Q2 24	+11.1%	+10.2%
Q3 24	+11.0%	+18.3%
Q4 24	+11.1%	+10.5%
Q1 25	+10.9%	+9.6%
Q2 25	+13.8%	+10.7%
Q3 25	+15.7%	+14.6%
Q4 25	+17.0%	+14.8%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$453.4K	3.7%
Q2 22	$121.0K	1.0%
Q3 22	$393.2K	2.9%
Q4 22	$426.6K	2.9%
Q1 23	$533.6K	3.4%
Q2 23	$568.5K	3.5%
Q3 23	$533.7K	3.2%
Q4 23	$551.1K	3.2%
Q1 24	$628.6K	3.6%
Q2 24	$609.1K	3.4%
Q3 24	$630.0K	3.4%
Q4 24	$656.8K	3.4%
Q1 25	$826.1K	4.2%
Q2 25	$730.6K	3.6%
Q3 25	$0	0.0%
Q4 25	$696.2K	3.1%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 22	$519.1K	$3M	$3M
Q2 22	$662.6K	$2M	$3M
Q3 22	$491.6K	$3M	$3M
Q4 22	$604.7K	$3M	$4M
Q1 23	$793.7K	$4M	$3M
Q2 23	$962.0K	$3M	$3M
Q3 23	$452.6K	$4M	$3M
Q4 23	$650.4K	$4M	$3M
Q1 24	$821.0K	$4M	$4M
Q2 24	$801.1K	$4M	$3M
Q3 24	$639.5K	$4M	$4M
Q4 24	$570.0K	$4M	$5M
Q1 25	$624.2K	$5M	$4M
Q2 25	$877.4K	$4M	$4M
Q3 25	$674.4K	$4M	$5M
Q4 25	$799.0K	$5M	$5M

Revenue Segments

Quarter

Revenue by Geography

Quarter	International	United States
Q3 23	$3M	$14M
Q1 24	$4M	$13M
Q2 24	$2M	$15M
Q3 24	$3M	$15M
Q4 24	$3M	$17M
Q1 25	$4M	$16M
Q2 25	$2M	$18M
Q3 25	$3M	$18M
Q4 25	$4M	$18M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$50M	$500.1K	$51M
Q2 22	$52M	$0	$52M
Q3 22	$56M	$0	$56M
Q4 22	$58M	$0	$58M
Q1 23	$43M	$0	$43M
Q2 23	$46M	$0	$46M
Q3 23	$47M	$0	$47M
Q4 23	$50M	$0	$50M
Q1 24	$45M	$0	$45M
Q2 24	$49M	$0	$49M
Q3 24	$52M	$0	$52M
Q4 24	$52M	$0	$52M
Q1 25	$50M	$0	$50M
Q2 25	$53M	$0	$53M
Q3 25	$57M	$0	$57M
Q4 25	$51M	$0	$51M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 22	13M	+0.2%	+1.1%
Q2 22	13M	-0.2%	+0.6%
Q3 22	13M	-0.0%	+0.2%
Q4 22	13M	-0.0%	-0.0%
Q1 23	13M	+0.5%	+0.2%
Q2 23	13M	+0.3%	+0.7%
Q3 23	13M	+0.1%	+0.8%
Q4 23	13M	+0.0%	+0.9%
Q1 24	13M	+0.1%	+0.5%
Q2 24	13M	+0.1%	+0.3%
Q3 24	13M	+0.2%	+0.3%
Q4 24	13M	+0.0%	+0.3%
Q1 25	13M	+0.3%	+0.6%
Q2 25	13M	+0.0%	+0.6%
Q3 25	13M	+0.2%	+0.6%
Q4 25	13M	+0.1%	+0.7%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 22	$111.9K	110
Q2 22	$115.7K	110
Q3 22	$121.9K	110
Q4 22	$120.8K	123
Q1 23	$125.8K	123
Q2 23	$131.1K	123
Q3 23	$134.2K	123
Q4 23	$117.9K	148
Q1 24	$118.9K	148
Q2 24	$121.1K	148
Q3 24	$123.8K	148
Q4 24	$121.2K	160
Q1 25	$121.9K	160
Q2 25	$127.6K	160
Q3 25	$132.5K	160
Q4 25	$136.7K	166

Revenue / Employee